+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Portable Fluorescence Immunoassay Analyzer Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6151659
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Portable Fluorescence Immunoassay Analyzer Market is projected to reach USD 4.45 Billion in 2026. It is expected to continue growing at a CAGR of 12.30%, reaching USD 8.91 Billion by 2032.

Portable Fluorescence Immunoassay Analyzers Enable Faster Decentralized Testing

Portable fluorescence immunoassay analyzers are compact diagnostic platforms that detect target biomarkers through fluorescent labels and immunochemical reactions. Their value is strongest where rapid, instrument-assisted results are needed outside centralized laboratories, including clinics, emergency settings, physician offices, pharmacies, field programs, and veterinary or occupational-health environments. Adoption is shaped by analytical performance, assay availability, workflow simplicity, connectivity, consumable stability, and compliance with local diagnostic regulations.

Decentralized Care and Connectivity Are Reshaping Analyzer Deployment

The landscape is shifting from centralized testing toward distributed workflows that place diagnostics closer to patients. Demand is supported by faster clinical decision-making, pressure to reduce laboratory bottlenecks, and the need for testing in facilities with limited infrastructure. Instruments that combine short turnaround times with guided operation, battery capability, rugged design, quality controls, and secure data transfer are better positioned for decentralized use. Procurement decisions increasingly evaluate the complete workflow, including sample preparation, reagent logistics, calibration, maintenance, result interpretation, and integration with laboratory or health-information systems.

Artificial Intelligence Improves Workflow Support While Preserving Analytical Oversight

Artificial intelligence can strengthen portable immunoassay workflows through image and signal interpretation, quality-control checks, anomaly detection, predictive maintenance, inventory planning, and decision-support interfaces. These applications may reduce operator variability and help identify invalid runs or results requiring confirmation. However, AI does not replace assay validation, reference methods, clinical judgment, or regulatory review. Successful implementation requires representative training data, transparent performance documentation, cybersecurity controls, human oversight, and monitoring for drift across instruments, populations, sample types, and operating conditions.

Regional Conditions Determine How Portable Testing Scales

North America emphasizes regulatory compliance, interoperability, decentralized-care efficiency, and integration with established clinical networks. Europe is influenced by harmonized requirements alongside national procurement and reimbursement structures, with strong attention to quality systems and data protection. Asia-Pacific combines advanced hospital systems with large rural and community-care needs, making portability, affordability, multilingual usability, and supply reliability important. Latin America places particular value on access, operational simplicity, and deployment beyond major urban centers. The Middle East is supported by investments in modern healthcare infrastructure and centralized purchasing, while environmental resilience and workforce training remain relevant. Africa presents substantial opportunities for near-patient and outreach testing, with implementation dependent on power stability, climate tolerance, distribution, external quality assessment, and local technical capacity.

Economic and Institutional Groupings Shape Procurement Priorities

ASEAN markets commonly prioritize scalable primary-care access, cross-border supply resilience, and solutions adaptable to varied regulatory and infrastructure conditions. BRICS members span advanced and emerging health systems, creating demand for localized manufacturing, workforce development, cost-conscious procurement, and broader diagnostic reach. The European Union places weight on conformity, post-market surveillance, interoperability, and consistent quality across member states. G7 health systems generally emphasize evidence generation, cybersecurity, integration, and reliable performance in high-throughput and decentralized settings. GCC countries often focus on rapid modernization, centralized purchasing, specialist care, and deployment across geographically dispersed facilities. NATO members may additionally value resilient logistics, emergency preparedness, and interoperable testing capacity for civilian and contingency applications.

Country-Level Priorities Range From Digital Integration to Access Expansion

Australia’s dispersed population increases the importance of remote deployment, logistics, and telehealth connectivity. Brazil and Mexico require solutions suited to heterogeneous infrastructure and broad geographic coverage. Canada emphasizes access across remote and Indigenous communities alongside integration with provincial care systems. China and India present large, diverse care environments in which manufacturing scale, affordability, regulatory alignment, and rural usability are important. France, Germany, Italy, and Spain balance decentralized access with rigorous quality, data, procurement, and health-system integration requirements. Japan and South Korea emphasize precision, automation, compact design, and compatibility with technologically advanced clinical workflows. Russia’s deployment considerations include geographic reach, supply continuity, and local operating conditions. The United Kingdom and United States place strong emphasis on evidence, regulatory compliance, interoperability, cybersecurity, and integration into distributed care pathways.

Leaders Should Build Around Validated Workflows, Not Devices Alone

Industry leaders should define target use cases by setting, operator, specimen, turnaround requirement, and clinical decision before selecting instrument features. They should validate assays across relevant populations and operating conditions, establish clear rules for confirmatory testing, and document quality-control procedures for decentralized users. Partnerships with laboratories, health systems, public-health agencies, distributors, and local service providers can improve implementation. Product strategies should include secure connectivity, accessible training, multilingual instructions, preventive maintenance, consumable traceability, and contingency plans for power or supply interruptions. Leaders should also monitor real-world performance, adoption barriers, data governance, and regulatory changes so that product updates remain clinically useful and operationally sustainable.

Research Methodology Combines Market-Reference Scope With Evidence-Based Interpretation

This executive summary uses the defined scope of portable fluorescence immunoassay analyzers and interprets adoption through established diagnostic, regulatory, clinical, operational, and infrastructure factors. The analysis is organized across the required regions, economic and institutional groups, and countries to identify recurring implementation patterns rather than produce numerical market estimates. Insights should be validated against current regulatory documents, peer-reviewed clinical evidence, procurement records, laboratory-quality standards, health-system policies, and interviews with qualified stakeholders. Because assay performance and requirements vary by intended use, conclusions should be applied only after reviewing product-specific validation, jurisdiction-specific authorization, and local workflow conditions.

Portable Immunoassay Platforms Will Matter Most Where Speed Meets Practical Access

Portable fluorescence immunoassay analyzers address a persistent need for timely, instrument-supported testing closer to patients. Their impact depends less on portability alone than on the combined strength of assay evidence, operator usability, connectivity, quality management, service support, and fit with local care pathways. Regional and country differences will continue to shape deployment, while AI can add value when governed with transparency and clinical oversight. Organizations that treat these analyzers as integrated diagnostic workflows-rather than standalone hardware-will be better equipped to expand reliable near-patient testing responsibly.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Portable Fluorescence Immunoassay Analyzer Market, by Product Type
7.1. Introduction
7.2. Cartridge Systems
7.3. Lateral Flow Readers
7.4. Microfluidic Analyzers
8. Portable Fluorescence Immunoassay Analyzer Market, by Sample Type
8.1. Introduction
8.2. Blood
8.3. Saliva
8.4. Serum
8.5. Urine
9. Portable Fluorescence Immunoassay Analyzer Market, by Technology
9.1. Introduction
9.2. Lab On Chip
9.3. Lateral Flow Immunoassay
9.4. Microfluidic Technology
10. Portable Fluorescence Immunoassay Analyzer Market, by Application
10.1. Introduction
10.2. Cancer Biomarkers
10.2.1. Ca-125
10.2.2. Cea
10.2.3. Psa
10.3. Cardiac Markers
10.3.1. Ck-Mb
10.3.2. Myoglobin
10.3.3. Troponin
10.4. Hormone Testing
10.4.1. Reproductive Hormones
10.4.2. Thyroid Hormones
10.5. Infectious Disease
10.5.1. Covid-19
10.5.2. Hepatitis
10.5.3. Hiv
11. Portable Fluorescence Immunoassay Analyzer Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals
11.4. Point Of Care Clinics
11.5. Research Institutes
12. Portable Fluorescence Immunoassay Analyzer Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Channels
13. Portable Fluorescence Immunoassay Analyzer Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Portable Fluorescence Immunoassay Analyzer Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Portable Fluorescence Immunoassay Analyzer Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Becton, Dickinson and Company
17.3. Bio-Rad Laboratories, Inc.
17.4. bioMérieux SA
17.5. Boditech Medical Inc.
17.6. Danaher Corporation
17.7. EKF Diagnostics Holdings plc
17.8. F. Hoffmann-La Roche AG
17.9. Hologic, Inc.
17.10. LumiraDx UK Ltd.
17.11. PerkinElmer, Inc.
17.12. Qiagen N.V.
17.13. QuidelOrtho Corporation
17.14. Response Biomedical Corp.
17.15. Siemens Healthineers AG
17.16. Sysmex Corporation
17.17. Thermo Fisher Scientific Inc.
17.18. Werfen, S.A.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Portable Fluorescence Immunoassay Analyzer Market, Years Considered for the Study
FIGURE 2. Global Portable Fluorescence Immunoassay Analyzer Market, Research Design
FIGURE 3. Global Portable Fluorescence Immunoassay Analyzer Market, Research Framework
FIGURE 4. Global Portable Fluorescence Immunoassay Analyzer Market, Data Triangulation
FIGURE 5. Global Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Portable Fluorescence Immunoassay Analyzer Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Portable Fluorescence Immunoassay Analyzer Market Segmentation & Coverage
TABLE 2. Global Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 3. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Cartridge Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cartridge Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cartridge Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Lateral Flow Readers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Lateral Flow Readers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Lateral Flow Readers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Microfluidic Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Microfluidic Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Microfluidic Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 14. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 27. Global Lab On Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Lab On Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Lab On Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Lateral Flow Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Lateral Flow Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Lateral Flow Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Microfluidic Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Microfluidic Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Microfluidic Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 37. Global Cancer Biomarkers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Cancer Biomarkers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Cancer Biomarkers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Ca-125 Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ca-125 Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ca-125 Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cea Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cea Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cea Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Psa Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Psa Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Psa Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Cardiac Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Cardiac Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Cardiac Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Ck-Mb Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Ck-Mb Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Ck-Mb Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Myoglobin Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Myoglobin Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Myoglobin Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Troponin Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Troponin Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Troponin Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Hormone Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Hormone Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Hormone Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Reproductive Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Reproductive Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Reproductive Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Thyroid Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Thyroid Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Thyroid Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Covid-19 Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Covid-19 Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Covid-19 Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Hepatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hepatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hepatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Hiv Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Hiv Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Hiv Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Point Of Care Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Point Of Care Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Point Of Care Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Online Channels Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Online Channels Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Online Channels Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 120. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 121. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 123. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 124. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 125. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 126. North America Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. North America Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 131. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 134. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 135. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 136. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 137. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Latin America Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 142. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 145. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 146. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 147. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 148. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Europe Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 153. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 156. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 157. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 158. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 159. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Middle East Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 164. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 167. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 168. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 169. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 170. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Africa Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 176. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 179. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 180. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 181. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 182. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. ASEAN Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 187. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 190. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 191. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 192. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 193. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. GCC Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 198. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 201. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 202. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 203. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 204. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. European Union Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 209. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 212. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 213. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 214. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 215. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. BRICS Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 220. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 223. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 224. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 225. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 226. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. G7 Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 231. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 234. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 235. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 236. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 237. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. NATO Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. Global Portable Fluorescence Immunoassay Analyzer Market Size, by Country, 2017-2032 (USD Million)
TABLE 240. United States Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 241. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 243. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 244. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 246. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 247. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 248. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 249. United States Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. United States Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. Canada Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 252. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 253. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 254. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 255. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 257. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 258. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 259. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 260. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Canada Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 263. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 265. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 268. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 269. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 270. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 271. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Mexico Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 274. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 276. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 279. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 280. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 281. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 282. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Brazil Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 285. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 286. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 287. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 290. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 291. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 292. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 293. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. United Kingdom Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. Germany Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 296. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 298. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 299. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 301. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 302. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Hormone Testing, 2017-2032 (USD Million)
TABLE 303. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 304. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Germany Portable Fluorescence Immunoassay Analyzer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 306. France Portable Fluorescence Immunoassay Analyzer Market Size, 2017-2032 (USD Million)
TABLE 307. France Portable Fluorescence Immunoassay Analyzer Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 308. France Portable Fluorescence Immunoassay Analyzer Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 309. France Portable Fluorescence Immunoassay Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 310. France Portable Fluorescence Immunoassay Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. France Portable Fluorescence Immunoassay Analyzer Market Size, by Cancer Biomarkers, 2017-2032 (USD Million)
TABLE 312. France Portable Fluo

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Boditech Medical Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • LumiraDx UK Ltd.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Response Biomedical Corp.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.